Telomerase contributes to tumorigenesis by a telomere length-independent mechanism
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Once immortalized, human cells are susceptible to transformation by introduction of an oncogene such as ras . Several lines of evidence now suggest that the maintenance of telomere length is a major determinant of replicative lifespan in human cells and thus of the immortalized state. The majority of human tumor cells acquire immortality through expression of the catalytic subunit of telomerase (hTERT), whereas others activate an alternative mechanism of telomere maintenance (ALT) that does not depend on the actions of telomerase. We have examined whether ALT could substitute for telomerase in the processes of transformation in vitro and tumorigenesis in vivo . Expression of oncogenic H-Ras in the immortal ALT cell line GM847 did not result in their transformation. However, subsequent ectopic expression of hTERT in these cells imparted a tumorigenic phenotype. Indeed, this outcome was also observed after introduction of a mutant hTERT that retained catalytic activity but was incapable of maintaining telomere length. These studies indicate that hTERT confers an additional function that is required for tumorigenesis but does not depend on its ability to maintain telomeres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Overexpression experiments in transgenic mice and in human cells have shown that TERT exhibits activities in cellular transformation (136-138), proliferation (139), stem cell biology (140-142), cell survival (143,144) and chromatin regulation (145).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [136]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, recent findings indicate that TERT promotes tumor development even in settings of ample telomere reserve, although the mechanisms underlying these telomere length-independent activities of TERT remain unclear9–13.”
From Conditional telomerase induction causes proliferation of hair follicle stem cells (2005) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Autoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80150-8 · Cited by 149
RetractedAutoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.003 · Cited by 31
RetractedThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Research works printed but not linked: 4
- Rich J N, Guo C, McLendon R E, Bigner D D, Wang X F, Counter C M. Cancer Res. 2001;61:3556–3560. [PubMed] [Google Scholar]
- Kuperwasser C, Pinkas J, Hurlbut G D, Naber S P, Jerry D J. Cancer Res. 2000;60:2723–2729. [PubMed] [Google Scholar]
- Zimonjic D, Brooks M W, Popescu N, Weinberg R A, Hahn W C. Cancer Res. 2001;61:8838–8844. [PubMed] [Google Scholar]
- Yeager T R, Neumann A A, Englezou A, Huschtscha L I, Noble J R, Reddel R R. Cancer Res. 1999;59:4175–4179. [PubMed] [Google Scholar]
Cited by
Items 201–300 of 434
Sun, B., Huang, Q., Liu, S., Chen, M., Hawks, C. L., Wang, L., Zhang, C., & Hornsby, P. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1376 · Cited by 41
“In an ALT cell line, SV40 TAg and Ras were insufficient for tumorigenicity, and hTERT was required (47).”
BackgroundDelgado, J.-P., Parouchev, A., Allain, J.-É., Pennarun, G., Gauthier, L., Dutrillaux, A., Dutrillaux, B., Santo, J. P. D., Capron, F., Boussin, F. D., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208089 · Cited by 38
“Immortalized clones can emerge at a low frequency after activation of hTERT, the catalytic subunit of the telomerase reverse transcriptase enzyme (Counter et al, 1998) or alternative mechanisms (Henson et al., 2002; Stewart et al., 2002).”
BackgroundTelomerase as a therapeutic target in cancer
Gellert, G. C., Jackson, S. R., Dikmen, Z. G., Wright, W. E., & Shay, J. W. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.009 · Cited by 37
Belgiovine, C., Chiodi, I., & Mondello, C. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167811 · Cited by 42
“In support of this hypothesis, Stewart et al. (2002) showed that the immortal human fibroblast cell line GM847, which is transformed with H-RasV12 oncoprotein, lacks telomerase activity and exhibits the ALT phenotype, did not form tumors in immunodeficient nude mice, whereas it became tumorigenic…”
HSF1, A Versatile Factor in Tumorogenesis
Calderwood, S. K. (2012) · Current Molecular Medicine · doi:10.2174/156652412803306675 · Cited by 35
“Cell divisions are “counted” by a molecular mechanism involving the telomere structures on the ends of chromosomes [45, 46].”
BackgroundCDC5L Promotes hTERT Expression and Colorectal Tumor Growth
Li, J., Zhang, N., Zhang, R., Sun, L., Yu, W., Guo, W., Gao, Y., Li, M., Liu, W., Liang, P., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475916 · Cited by 36
General morphological and biological features of neoplasms: integration of molecular findings
Díaz-Cano, S. J. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02937.x · Cited by 37
“The presence of this factor determines the availability of the telomerase function.(62) The TERT protein has a high turnover rate and its expression is regulated by factors that promote growth (c-MYC, v-k-ras, Bcl-2 and E6) and inhibiting factors (RB and p53) that promote cell death or that block cell division.”
BackgroundDolcetti, R., & De Rossi, A. (2012) · Medicinal Research Reviews · doi:10.1002/med.20211 · Cited by 35
Cardiac telomere length in heart development, function, and disease
Booth, S. A., & Charchar, F. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2017 · Cited by 39
“In addition to being the primary maintenance mechanism of TL, telomerase is involved in many other cellular processes, including growth (140), proliferation (28, 139), and mitochondrial function (2).”
BackgroundTogtema, M., Jackson, R., Richard, C., Niccoli, S., & Zehbe, I. (2015) · Virology · doi:10.1016/j.virol.2015.07.025 · Cited by 35
“In addition, elongation of telomeres, either by activation of hTERT or ALT mechanisms, must be initiated (Stewart et al., 2002).”
BackgroundTelomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases
Hong, J., & Yun, C. (2019) · Cells · doi:10.3390/cells8050392 · Cited by 35
“In detail, a catalytically active mutant form of TERT without the ability to elongate telomeres has been reported to cause oncogenic transformation [92], suggesting that TERT exerts non-canonical (telomeric-independent) functions.”
BackgroundFu, C., Liu, C., Lindvall, C. J., Xu, D., & Ernberg, I. T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20594 · Cited by 34
Benedetti, S., Uno, N., Hoshiya, H., Ragazzi, M., Ferrari, G., Kazuki, Y., Moyle, L. A., Tonlorenzi, R., Lombardo, A., Chaouch, S., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607284 · Cited by 35
“Immortalised human mesoangioblasts are not tumorigenic and their immortalisation can be reverted by Cre recombinase and ganciclovir High proliferation rate and maintenance of telomerase expression are associated with cell transformation (Stewart et al, 2002).”
BackgroundFunctional Significance of Minor Structural and Expression Changes in Stress Chaperone Mortalin
Deocaris, C. C., Widodo, N., Ishii, T., Kaul, S. C., & Wadhwa, R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1404.007 · Cited by 32
How does the body know how old it is? Introducing the epigenetic clock hypothesis
Mitteldorf, J. J. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913090113 · Cited by 31
Cerchiara, J. A., Risques, R. A., Prunkard, D. E., Smith, J. R., Kane, O. J., & Boersma, P. D. (2017) · Ecology and Evolution · doi:10.1002/ece3.3128 · Cited by 33
“Telomerase is able to elongate telomeres (Greider & Blackburn, 1985); however, it often has diminished activity in adults, particularly in long- lived species (Dong, Masutomi, & Hahn, 2005; Haussmann et al., 2007; Hornsby, 2007; Stewart et al., 2002; Tollefsbol & Andrews, 2001).”
BackgroundModeling aging and cancer in the telomerase knockout mouse
Chang, S. S. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.020 · Cited by 38
The telomerase cycle: normal and pathological aspects
Brunori, M., Luciano, P., Gilson, É., & G�li, V. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0616-2 · Cited by 34
Dyskerin, telomerase and the DNA damage response
Gu, B.-W., Bessler, M., & Mason, P. J. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7265 · Cited by 31
Telomeres and Telomerase: A Modern Fountain of Youth?
de Magalhães, J. P., & Toussaint, O. (2004) · Rejuvenation Research · doi:10.1089/1549168041553044 · Cited by 37
“80 For example recent study found that hTERT expression HDFs leads to an upregulation of a potent growth factor involved in .”
Telomerase targeted therapy in cancer and cancer stem cells.
Xu, Y., He, K., & Goldkorn, A. (2011) · PubMed · Cited by 33
Dissecting the non-canonical functions of telomerase
Parkinson, E. K., Fitchett, C., & Cereser, B. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167813 · Cited by 29
“Surprisingly, TERT-HA was able to substitute for TERT in the latter assay, thus separating telomere lengthening from the induction of tumors (Stewart et al., 2002).”
BackgroundRicca, I., Compagno, M., Ladetto, M., Rocci, A., Dell'Aquila, M., Omedè, P., Marco, F. D., D’Antico, S., Caracciolo, D., Ferrero, D., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403652 · Cited by 31
Regulation of Telomerase by Human Papillomaviruses
Galloway, D. A., Gewin, L. C., Myers, H. E., LUO, W., Grandori, C., Katzenellenbogen, R. A., & McDougall, J. K. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.041 · Cited by 37
“Telomerase may play additional roles in tumorigenic transformation, because hTERT was necessary for transformation of cells that maintained long telomeres by the ALT pathway (Stewart et al. 2002).”
BackgroundInfluentialXue, Y., Li, L., Zhang, D., Wu, K., Chen, Y., Zeng, J., Wang, X., & He, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027748 · Cited by 30
“It has been shown previously that the ALT pathway does not substitute for telomerase in the process of tumorigenesis in vivo [23]; therefore, we established the tumor xenograft by subcutaneous injection of 1610(6) T24, T24/PCI, or surviving T24/”
MethodCHUNG, S. S., Adekoya, D., ENENMOH, I., Clarke, O., Wang, P., SARKYSSIAN, M., Wu, Y., & Vadgama, J. V. (2017) · Anticancer Research · doi:10.21873/anticanres.11336 · Cited by 31
Zhao, T., HU, F., Qiao, B., Chen, Z., & Tao, Q. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2927 · Cited by 29
Nucleolar localization of TERT is unrelated to telomerase function in human cells
Lin, J., Jin, R., Zhang, B., Chen, H., Bai, Y. X., Yang, P. X., Han, S. W., Xie, Y. H., Huang, P. T., Huang, C., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.024091 · Cited by 32
“It is now clear that TERT can facilitate human cellular tumorigenesis through pathways other than telomere-length maintenance (Stewart et al., 2002), and that it possesses an anti- Journal of Cell Science 121 (13) Fig.”
BackgroundPirzio, L. M., Freulet-Marrière, M.-A., Bai, Y., Fouladi, B., Murnane, J. P., Sabatier, L., & Desmaze, C. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077470 · Cited by 29
“Telomerase can protect chromosomes from end-to-end fusion not only by lengthening the telomere but also by providing a cap at the end of the chromosome (Melek and Shippen, 1996; Zhu et al., 1999; Blackburn, 2001; Stewart et al., 2002).”
BackgroundHaakensen, V. D., Nowak, A. K., Ellingsen, E. B., Farooqi, S. J., Bjaanæs, M. M., Horndalsveen, H., McCulloch, T., Grundberg, O., Cedrés, S., & Helland, Å. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02905-3 · Cited by 30
Gocha, A. R. S., Harris, J. M., & Groden, J. L. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.11.006 · Cited by 33
“Oncogenic H-RAS expression in immortalized human GM847 ALT fibroblasts does not confer transformation, as these cells cannot form tumors following injection into immunocompromised mice; however, expression of telomerase in these cells permits tumor formation [9].”
Human Telomerase Reverse Transcriptase (hTERT) Positively Regulates 26S Proteasome Activity
Im, E., Yoon, J. B., Lee, H., & Chung, K. C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25607 · Cited by 28
“Recently, research has focused on extratelomeric hTERT function. hTERT promotes tumorigenesis (Stewart et al., 2002), and directly regulates gene expression (Smith et al., 2003).”
BackgroundSeryl tRNA synthetase cooperates with POT1 to regulate telomere length and cellular senescence
Li, Y., Li, X., Cao, M., Jiang, Y., Yan, J., Liu, Z., Yang, R., Chen, X., Sun, P., Xiang, R., et al. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0078-1 · Cited by 28
Order of genetic events is critical determinant of aberrations in chromosome count and structure
Fauth, C., O’Hare, M. J., Lederer, G., Jat, P., & Speicher, M. R. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20051 · Cited by 30
“DePinho, 2002) and may even contribute to tumorigenesis (Stewart et al., 2002).”
BackgroundInfluentialWootton, M., Steeghs, K., Watt, D. J., Munro, J., Gordon, K., Ireland, H., Morrison, V., Behan, W. M. H., & Parkinson, E. K. (2003) · Human Gene Therapy · doi:10.1089/104303403769211682 · Cited by 30
Kumar, M., Lechel, A., & Güneş, Ç. (2016) · Genes · doi:10.3390/genes7080043 · Cited by 30
“It was shown that a catalytically inactive hTERT can promote tumor formation, supporting a telomere length-independent functional role of telomerase in tumorigenesis [110].”
BackgroundBabizhayev, M. A., & Yegorov, Y. E. (2014) · Current Drug Delivery · doi:10.2174/15672018113106660062 · Cited by 29
Liu, T., Liang, X., Li, B., Björkholm, M., Jia, J., & Xu, D. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.208 · Cited by 29
Li, X., Xu, X., Fang, J., Wang, L., Mu, Y., Zhang, P., Yao, Z., Ma, Z., & Liu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.9339 · Cited by 29
“There is also evidence showed that cotransfection of TERT with H-ras can transform immortalized cells [26].”
BackgroundPan-Cancer Analysis of Alternative Lengthening of Telomere Activity
Sung, J., Lim, H., Joung, J., & Park, W. (2020) · Cancers · doi:10.3390/cancers12082207 · Cited by 28
Telomerase regulation in hematological cancers: A matter of stemness?
Deville, L., Hillion, J., & Ségal-Bendirdjian, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.016 · Cited by 29
“5 occurs at each cycle of replication, but it also presents non conventional roles including capping and anti-apoptotic functions, activation of pro-proliferative signaling pathways, modulation of specification of hematopoietic stem/progenitor cells during vertebrate development [16, 17].”
BackgroundFridman, A. L., Tang, L., Kulaeva, O. I., Ye, B., Li, Q., Nahhas, F. A., Roberts, P. C., Land, S. J., Abrams, J., & Tainsky, M. A. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.9.879 · Cited by 32
“Immortal cells maintain stable telomere lengths by either activating telomerase or by alternative lengthening of telomeres (ALT) (16,17).”
BackgroundThe Role of Telomeres and Telomerase in Cancer Research
Stewart, S. A., & Bertuch, A. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1373 · Cited by 30
Self-citationhTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications
Deville, L., Hillion, J., Pendino, F., Samy, M., Nguyen, É., & Ségal-Bendirdjian, E. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0979 · Cited by 25
“Furthermore, it has been established that telomerase is endowed with additional functions that are independent of the telomere elongating activity (12-14).”
BackgroundZhao, P., Wang, C., Fu, Z., You, Y., Cheng, Y., Lu, X., Lu, A., Liu, N., Pu, P., Kang, C., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.2.361 · Cited by 25
“On the other hand, recent studies have suggested that hTERT contributes to tumorigenesis by a telomere length-independent mechanism (33).”
BackgroundHartig, J. S., & Kool, E. T. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh149 · Cited by 28
“Unfortunately, telomerase enzyme preparations exhibit low activity in vitro, requiring amplification steps to observe the very short elongations that typically occur ( 6 ,7).”
BackgroundMicroarray analyses in bladder cancer cells: Inhibition of hTERT expression down‐regulates EGFR
Kraemer, K., Schmidt, U., Fuessel, S., Herr, A., Wirth, M. P., & Meye, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21975 · Cited by 28
“In contrast, hTERT can impair cell growth immediately and independent from its function in telomere lengthening.(2,5,9) An immediate proliferation stop was initiated by targeting the hTERT mRNA with ribozymes or antisense oligodeoxynucleotides (AS-ODNs).”
BackgroundCharacterization of primary wilms tumor cultures as an in vitro model
Wegert, J., Bausenwein, S., Roth, S., Graf, N. M., Geissinger, E., & Gessler, M. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20936 · Cited by 24
“Telomere length of early passages was not predictive of subsequent life span, suggesting that alternative functions of hTERT beyond telomere lengthening may be relevant (Stewart et al., 2002).”
BackgroundLong Telomeres Bypass the Requirement for Telomere Maintenance in Human Tumorigenesis
Taboski, M. A. S., Sealey, D., Dorrens, J., Tayade, C., Betts, D. H., & Harrington, L. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.12.004 · Cited by 24
“In contrast, when TERT is over-expressed, its ability to stimulate proliferation does not always depend on catalytic activity, e.g. in ALT cells (Stewart et al., 2002) or murine hair follicles (Flores et al., 2005; Parkinson et al., 2008; Sarin et al., 2005).”
BackgroundBrachner, A., Sasgary, S., Pirker, C., Rodgarkia‐Dara, C., Mikula, M., Mikulits, W., Bergmeister, H., Setinek, U., Wieser, M., Chin, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2839 · Cited by 24
“Besides the well-characterized function in the telomerase complex, hTERT was suggested to harbor telomerase-independent oncogenic functions ( 13 , 14).”
BackgroundInfluentialXu, T., He, K., Wang, L., & Goldkorn, A. (2011) · The Prostate · doi:10.1002/pros.21355 · Cited by 23
“In support of a unique telomerase role in CPC, ectopic overexpression of telomerase in cancer cell lines has indeed been shown to enhance tumor initiation, perhaps reflecting a potentiation of the CPCphenotype [24,26].”
BackgroundThe hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & LLeonart, M. E. (2015) · Inside the Cell · doi:10.1002/icl3.1039 · Cited by 37
Sekulovic, S., Gylfadottir, V., Vulto, I. M., Gasparetto, M., Even, Y., Brookes, C., Smith, C. A., Eaves, C. J., Lansdorp, P. M., Rossi, F. M. V., et al. (2011) · Blood · doi:10.1182/blood-2010-11-319632 · Cited by 26
The Tale of the Telomere: Implications for Prevention and Treatment of Skin Cancers
Gilchrest, B. A., & Eller, M. S. (2005) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2005.200406.x · Cited by 23
Zhu, S., Wang, J., Zellmer, L., Xu, N., Liu, M., Hu, Y., Ma, H., Deng, F., Yang, W., & Liao, D. J. (2022) · Journal of Cancer · doi:10.7150/jca.72628 · Cited by 25
Cao, Y., Huschtscha, L. I., Nouwens, A. S., Pickett, H. A., Neumann, A. A., Chang, A. C.-M., Toouli, C. D., Bryan, T. M., & Reddel, R. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6377 · Cited by 24
“Alternatively, cells with increased hTERT may have a growth advantage due to putative telomere lengthindependent functions of hTERT (46, 47).”
BackgroundLiao, Y., Gao, Y., Chang, A., Li, Z., Wang, H., Cao, J., Gu, W., & Tang, R. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15854 · Cited by 21
Fleisig, H. B., & Wong, J. M. Y. (2011) · Oncogene · doi:10.1038/onc.2011.292 · Cited by 23
“This implies that the role of telomerase activity in cancer development goes beyond telomere maintenance (”
BackgroundLeukemic cells with increased telomerase activity exhibit resistance to imatinib
Yamada, O., Kawauchi, K., Akiyama, M., Ozaki, K., Motoji, T., Adachi, T., & Aikawa, E. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802043861 · Cited by 21
Babizhayev, M. A., & Yegorov, Y. E. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35515 · Cited by 23
Coussens, M. J., Yamazaki, Y., Moisyadi, S., Suganuma, R., Yanagimachi, R., & Allsopp, R. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.052167 · Cited by 25
“In some human cancer cells, TERT has been shown to have protumorigenic properties independent of telomere length maintenance [32], and suppression of TERT expression in human fibroblasts leads to attenuation of the DNA damage response [33].”
BackgroundTelomerase inhibition impairs tumor growth in glioblastoma xenografts
Falchetti, M. L., Fiorenzo, P., Mongiardi, M. P., Petrucci, G., Montano, N., Maira, G., Pierconti, F., Larocca, L. M., Levi, A., & Pallini, R. (2006) · Neurological Research · doi:10.1179/016164106x116818 · Cited by 21
Telomere maintenance in sarcomas
Johnson, J. E., & Broccoli, D. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3281214423 · Cited by 22
Xin, X., Senthilkumar, P. K., Schnoor, J. L., & Ludewig, G. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-5187-y · Cited by 20
“Shay and Bacchetti found telomerase activation in ~90 % of cancers (Shay and Bacchetti 1997), which indicates that telomerase activity and telomere length are highly correlated to tumor development (Bailey and Murnane 2006; Eisenberg 2011; Kim et al. 1994; Stewart et al. 2002; Wu et al. 2003).”
BackgroundVidaurreta, M., Maestro, M.-L., Rafael, S., Veganzones, S., Sanz-Casla, M.-T., Cerdán, J., & Arroyo, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i28.3868 · Cited by 20
Telomerase Expression in Individuals With Chronic and Aggressive Periodontitis
Katarkar, A., Arindam, S., Mukherjee, S., Kundu, D., Bandyopadhyay, P., & Chaudhuri, K. (2015) · Journal of Periodontology · doi:10.1902/jop.2015.140540 · Cited by 20
Tárkányi, I., Horváth, A., Szatmári, I., Eizert, H., Vámosi, G., Damjanovich, S., Ségal-Bendirdjian, E., & Aradi, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.041 · Cited by 20
Siddiqa, A., Cavazos, D., & Marciniak, R. A. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.378 · Cited by 20
Amyloid β and Tumorigenesis: Amyloid β-Induced Telomere Dysfunction in Tumor Cells
Qin, H., Wang, J., Ren, J., & Qu, X. (2019) · CCS Chemistry · doi:10.31635/ccschem.019.20180034 · Cited by 19
Leyba, K. R., Garcia‐Smith, R., Swaminathan, R., Jones, A., Russell, J., Joste, N. E., Bisoffi, M., & Trujillo, K. A. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24469 · Cited by 20
“Recent evidence also suggests that the catalytic subunit of telomerase, TERT, can promote tumorigenic transformation independent of its ability to maintain telomeres [56].”
BackgroundPrasad, R. R., Mishra, D. K., Kumar, M., & Yadava, P. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08673 · Cited by 19
Chang, H., & Delany, M. E. (2006) · Gene · doi:10.1016/j.gene.2006.04.021 · Cited by 21
Voglauer, R., Grillari, J., Fortschegger, K., Wieser, M., Sterovsky, T., Günsberg, P., Katinger, H. W. D., & Pfragner, R. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.4.961 · Cited by 21
Fujiwara, C., Muramatsu, Y., Nishii, M., Tokunaka, K., Tahara, H., Ueno, M., Yamori, T., Sugimoto, Y., & Seimiya, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-33139-x · Cited by 21
Telomerase as a clinical target: Current strategies and potential applications
Fleisig, H. B., & Wong, J. M. Y. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.011 · Cited by 23
Anticancer Therapy Targeting Telomeres and Telomerase: Current Status
Parkinson, E. K., & Minty, F. (2007) · BioDrugs · doi:10.2165/00063030-200721060-00005 · Cited by 22
Telomeres, Telomerase, Stress, and Aging
Lin, J., Epel, E. S., & Blackburn, E. H. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb002065 · Cited by 21
PinX1: a sought-after major tumor suppressor at human chromosome 8p23
Zhou, X. Z. (2011) · Oncotarget · doi:10.18632/oncotarget.339 · Cited by 18
“Moreover, it has been shown that TERT overexpression extends life span in normal human cells in vitro [100102] and that short-term telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice [103], although long-term TERT overexpression promotes tumorigenesis in vitro or in vivo [92, 104-110…”
Li, S., Ferguson, M. J., Hawkins, C. J., Smith, C. A., & Elwood, N. J. (2006) · Leukemia · doi:10.1038/sj.leu.2404251 · Cited by 18
Clarke, C. J. P., Hii, L. L., Bolden, J. E., & Johnstone, R. W. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22386 · Cited by 19
“Other evidence in favour of such functions includes observations that overexpression of TERT increased proliferation of cells in vitro [Stewart et al., 2002] and the incidence of mammary tumours [Artandi et al.”
BackgroundTelomerase as a novel and potentially selective target for cancer chemotherapy
Parkinson, E. K. (2003) · Annals of Medicine · doi:10.1080/07853890310006361 · Cited by 19
Exploring the Native Human Antibody Repertoire to Create Antiviral Therapeutics
Dessain, S. K., Adekar, S. P., & Berry, J. D. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-72146-8_6 · Cited by 23
“In addition, hTERT has been shown to have many other functions that may be beneficial to hybrid cells, including an incompletely characterized tumor-promoting function that may be related to its antiapoptotic and growth factorstimulatory activities (Holt et al. 1999; Stewart et al. 2002; Kanzaki et al. 2003; Smith et…”
BackgroundSun, B., Chen, M., Hawks, C. L., & Hornsby, P. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1210 · Cited by 21
“In view of a previous report that despite being immortal, GM847 cells required expression of both Ras and hTERT for tumorigenicity in immunodeficient mice (6), we compared the properties of Ras-transduced cells and Ras/hTERT-transduced GM847 cells.”
BackgroundInfluentialTelomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis
García‐Castillo, J., Alcaraz‐Pérez, F., Martínez‐Balsalobre, E., García‐Moreno, D., Rossmann, M. P., Fernández-Lajarín, M., Bernabé‐García, M., Pérez‐Oliva, A. B., Rodríguez-Cortez, V., Bueno, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015528118 · Cited by 17
Telomeres and telomerase in normal and malignant B‐cells
Lobetti‐Bodoni, C., Bernocco, E., Genuardi, E., Boccadoro, M., & Ladetto, M. (2010) · Hematological Oncology · doi:10.1002/hon.937 · Cited by 18
Bates, S. E., Zhou, N. Y., Federico, L., Xia, L., & O'Connor, T. R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki542 · Cited by 16
“Telomerase also has a role in tumorigenesis ( 12 ).”
Molecular characterization of immortalized normal and dysplastic oral cell lines
Dickman, C. T., Towle, R. M., Saini, R., & Garnis, C. (2014) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12236 · Cited by 17
Kapitanov, G. (2012) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/20127107 · Cited by 16
“We can assume this since stem cells have higher degree of self-renewal than other cells, hence pn,n,m−1 ≥ pj,j,i,∀1 ≤ j ≤ n; 0 ≤ i ≤ m − 1 [44][24][43].”
Telomere Maintenance in Pediatric Cancer
Ackermann, S., & Fischer, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235836 · Cited by 16
The labeling efficiency of human telomeres is increased by double-strand PRINS
Yan, J., Chen, B.-Z., Bouchard, E., & Drouin, R. (2004) · Chromosoma · doi:10.1007/s00412-004-0310-8 · Cited by 18
“fluorescence in situ hybridization (FISH) while others within the same cell have very long telomeric sequences (Perrem et al. 2001; Stewart et al. 2002; Desmaze et al. 2003).”
BackgroundQin, Y., Guo, H. Y., Tang, B., & Yang, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2470 · Cited by 15
Yang, Y., Miao, Z., Zhang, H.-J., Wang, Y., Gao, J., & Feng, M. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00111.x · Cited by 15
Endorf, E. B., 青华, Aono, J., Terami, N., Doyon, G., Hyzny, E. J., Jones, K. L., Findeisen, H. M., & Bruemmer, D. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308717 · Cited by 15
Zhao, T., Hu, F., Liu, X., & Tao, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.5468 · Cited by 16
“Several studies have demonstrated that human TERT (hTERT) was implicated in the telomerase-mediated cellular transformation [6], proliferation [7], stemness [8] and cell survival [9].”
Blackburn, E. H. (2005) · Nature · doi:10.1038/436922a · Cited by 15
Alzoubi, H., Minasi, S., Gianno, F., Antonelli, M., Belardinilli, F., Giangaspero, F., Jaffrain‐Rea, M., & Buttarelli, F. R. (2022) · Endocrine Pathology · doi:10.1007/s12022-021-09702-0 · Cited by 14
González‐Moles, M. Á., Moya-González, E., García-Ferrera, A., Nieto-Casado, P., & Ramos‐García, P. (2022) · Cancers · doi:10.3390/cancers14153673 · Cited by 14
“Animal experimentation has shown that ectopic expression of TERT promotes tumor formation and growth [57–60], and its constitutive overexpression increases the survival and replicative activity of tumor cells, even in the absence of growth factors, oxygen, or glucose [57,61,62], while conversely a lack of TERT activit…”
BackgroundThe Telomerase Connection of the Brain and Its Implications for Neurodegenerative Diseases
Saretzki, G. C. (2022) · Stem Cells · doi:10.1093/stmcls/sxac078 · Cited by 14
Samassékou, O., Li, H., Hébert, J., Ntwari, A., Wang, H., Cliché, C. G., Bouchard, É. F., Huang, S., & Yan, J. (2011) · Neoplasia · doi:10.1593/neo.11358 · Cited by 15
“There have been some studies that have documented consistent differences in telomere lengths specific to unique chromosomes [21–24].”
BackgroundResultJayaprasad, A. G., Chandrasekharan, A., Jyothi, S., Sam, S. M. J., Santhoshkumar, T. R., & Pillai, M. R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130151 · Cited by 12
Metadata
- Authors
- Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., Popescu, N. C., & Weinberg, R. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Adult Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115; Departments of Medicine and Pathology, Harvard Medical School, Boston, MA 02115; Genzyme, Inc., One Kendall Square, Cambridge, MA 02139; Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, MD 20892; and Department of Biology, Massachusetts Institute of...
- Corresponding author
- Weinberg, Robert A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-22
- Volume
- 99
- Issue
- 20
- Pages
- 12606-12611
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC130507
- OpenAlex
- W2154837214
- Cited by
- 431
- References
- 53
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 11 · 2018: 5 · 2017: 14 · 2016: 21 · 2015: 18 · 2014: 22 · 2013: 15 · 2012: 18
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- American Association for Cancer Research
- W. M. Keck Foundation
- Ludwig Institute for Cancer Research
- National Institutes of Health
- National Cancer Institute (KO1CA94223, R01 CA78461, K01CA094223, R01CA078461)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- telomerase, hTERT, alternative lengthening of telomeres, carcinogenesis, cell transformation, cell immortalization, replicative lifespan
- MeSH terms
- Catalysis, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Glucose, Humans, Karyotyping, Kinetics, Luminescent Proteins, Microscopy, Fluorescence, Oxygen, Retroviridae, Time Factors, Tumor Cells, Cultured, Blotting, Western, Telomere, Telomerase, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.